APA (7th ed.) Citation

Lipton, R. B., Mosher, L., & Fountaine, R. J. (2026). Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study. Pain & Therapy, 15(1), 325. https://doi.org/10.1007/s40122-025-00800-z

Chicago Style (17th ed.) Citation

Lipton, Richard B., Linda Mosher, and Robert J. Fountaine. "Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study." Pain & Therapy 15, no. 1 (2026): 325. https://doi.org/10.1007/s40122-025-00800-z.

MLA (9th ed.) Citation

Lipton, Richard B., et al. "Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study." Pain & Therapy, vol. 15, no. 1, 2026, p. 325, https://doi.org/10.1007/s40122-025-00800-z.